In the British medical devices industry, there were 11 M&A deals announced in Q3 2024, worth a total value of $386.1m, according to GlobalData’s Deals Database. The $197.8m acquisition of Vectura Group by Molex Asia was the industry’s largest disclosed deal. GlobalData’s Medical Devices Industry Mergers and Acquisitions Deals by Top Themes in Q3 2024 report helps understand the pivotal themes steering M&A activity in the industry. Buy the report here.
In value terms, M&A activity in the UK increased by 24% in Q3 2024 compared with the previous quarter’s total of $312.7m and rose by 1439% as compared to Q3 2023. Related deal volume increased by 57% in Q3 2024 versus the previous quarter and was 57% higher than in Q3 2023.
The top-ranked financial advisors supporting these M&A deals in the UK in 9M 2024 were Cavendish Financial; Corporate Partners; Earlybird Venture Capital with 1, 1, 1 deals respectively.
The top-ranked legal advisors supporting these M&A deals in the UK in 9M 2024 were Lexence; Linklaters; Maples and Calder (Cayman) with 1, 1, 1 deals respectively.
For further understanding of GlobalData's Medical Devices Industry Mergers And Acquisitions Deals By Top Themes In Q3 2024 – Strategic Intelligence, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.